...S. Jabłońska; A. Stachow A case of IgG-χ multiple myeloma is reported with coexistent scleroderma-like skin lesions. Histological, histochemical, electron microscopic and immunohistochemical studies failed to reveal amyloid in the skin, muscles, intestine and kidney. No macroglossia or other...

..., instructions or products referred to in the content or advertisements. Skin grafting Multiple myeloma Cryoglobulinemia Extensive necrosis of the skin, muscle and bone Dcrmatologica 160: 125-130 (1980) A Case of Cryoglobulinémie Gangrene in Myeloma with Fatal Outcome Despite Successful Skin Grafting...

.... All the diagnostic studies for multiple myeloma were negative. However, 16 months later he developed this disease. Psoriasis Psoriatic arthritis Monoclonal paraproteinemia Multiple myeloma Corneal disease © 1984 S. Karger AG, Basel 1984 Copyright / Drug Dosage / Disclaimer Copyright...

...M.S. Doutre; C. Conri; C. Beylot; B. Fleury; H. Chapoulard; P. Bioulac Clinicopathologic findings are reported of a woman with plane xanthomatosis, multiple myeloma (IgGĸ) and normolipemia. Plasma lipoproteins were bound to the monoclonal immunoglobulin. The complex was separated...

... of scleromyxedema with multiple myeloma (8.7%) and macroglobulinemia Waldenström (3.5%). A man with scleromyxedema, IgG lambda paraproteinemia, and sclerodactylia – as a special sign of scleromyxedema – is reported. Melphalan is the drug of choice in serious cases, but not effective in sclerodactylia...

...H. Nakanishi; K. Takehara; Y. Soma; Y. Ishibashi A case of atypical scleroderma associated with multiple myeloma is reported. The patient was a 50-year-old male; morphea-like plaques with brownish pigmentation were scattered on the whole body and sclerodactylia-like changes, contracture of fingers...

...D.N. Atukorala; R.K. Joshi; A. Abanmi; M.T. Jeha A case of subcorneal pustular dermatosis (SCPD), as a presenting feature in a patient with multiple myeloma, is described. This is the seventh case report of this association and the first from the Middle East. Five of these cases, including...

...S. Sanchez-Politta; L. Favet; K. Kerl; P.-Y. Dietrich; V. Piguet Bortezomib (Velcade®) is a proteasome inhibitor recently developed and mainly used for the treatment of multiple myeloma. Bortezomib represents a novel class of drugs functioning as proteasome inhibitors. Skin complications...